Give the Gift of Emotional Growth This Holiday Season

PR NewswireNov 21 21:39

Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences

GlobeNewswireNov 18 20:00

Craig-Hallum Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating

Futu NewsNov 14 22:31 · Ratings

Express News | Skye Bioscience Inc - Expects Interim Data for Cbeyond Phase 2 Trial in Q2 2025

BreakingsNov 14 20:02

Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor

GlobeNewswireNov 14 20:00

Oppenheimer Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating, Maintains Target Price $21

Futu NewsNov 8 22:38 · Ratings